Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord
Authors:
- Charles H. TatorCTCharles H. Tator
- Molly S. ShoichetMSMolly S. Shoichet
- 1 July 2005
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 194 (1) , 106-119
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Catheter-Associated Masses in Patients Receiving Intrathecal Analgesic TherapyAnesthesia & Analgesia, 2003
- In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cordEuropean Journal of Neuroscience, 2002
- Intrathecal Administration of Epidermal Growth Factor and Fibroblast Growth Factor 2 Promotes Ependymal Proliferation and Functional Recovery after Spinal Cord Injury in Adult RatsJournal of Neurotrauma, 2002
- Delivery of Neurotrophic Factors to the Central Nervous SystemClinical Pharmacokinetics, 2001
- Basic Fibroblast Growth Factor (bFGF) Enhances Functional Recovery Following Severe Spinal Cord Injury to the RatExperimental Neurology, 2000
- Direct convective delivery of macromolecules to the spinal cordJournal of Neurosurgery, 1998
- Differential distribution of exogenous BDNF, NGF, and NT‐3 in the brain corresponds to the relative abundance and distribution of high‐affinity and low‐affinity neurotrophin receptorsJournal of Comparative Neurology, 1995
- Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up dataJournal of Neurosurgery, 1992
- Controlled and modulated release of basic fibroblast growth factorBiomaterials, 1991
- In vitro kinetics of basic fibroblast growth factor diffusion across a reconstituted corneal endotheliumJournal of Cellular Physiology, 1991